Почетна › Рак бешике › Ilinois › Chicago
Kliničke studije za Рак бешике u gradu Chicago, IL
Jedna studija za Рак бешике traži učesnike na lokaciji u gradu Chicago ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Тражи се учесникФаза 2
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Тражи се учесникФаза 2
- Rush MD Anderson Cancer Center, Chicago
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Тражи се учесникФаза 1
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Тражи се учесникФаза 1
- University of Chicago Hospital, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- и још 1
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Тражи се учесникФаза 1
- The University of Chicago Medical Center (UCMC), Chicago
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Тражи се учесникФаза 2
- Northwestern University, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 2
- University of Illinois Cancer Center, Chicago
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Тражи се учесникФаза 3
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Тражи се учесникФаза 3
- University of Illinois at Chicago, Chicago
- University of Chicago Medical Center, Chicago
Measuring Surgical Recovery After Radical Cystectomy
Тражи се учесникОпсервациона студија
- University of Chicago, Chicago
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Тражи се учесникФаза 1/2
- University of Chicago Medical Center ( Site 5037), Chicago
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Тражи се учесникФаза 3
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Тражи се учесникФаза 2
- UChicago Medicine - River East, Chicago
- University of Chicago Medical Center, Chicago
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Тражи се учесникФаза 1
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- University of Chicago Medical Center, Chicago
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
Тражи се учесникФаза 2
- Northwestern University, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Тражи се учесникФаза 1
- The University of Chicago Comprehensive Cancer Center, Chicago
Blue Light Cystoscopy With Cysview® Registry
Тражи се учесникОпсервациона студија
- Northwestern University, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Chicago
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
Тражи се учесникОпсервациона студија
- Jesse Brown Department Of Veterans Affairs Medical Center, Chicago
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
Тражи се учесник
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Studije za Рак бешике u drugim gradovima
- New York City, NY36 студија
- Nashville, TN31 студија
- Houston, TX31 студија
- Dallas, TX27 студија
- Boston, MA26 студија
- Washington, DC26 студија
- Los Angeles, CA25 студија
- Baltimore, MD24 студија
- Philadelphia, PA23 студија
- Edison, NJ23 студија
- St. Louis, MO22 студија
- Seattle, WA21 студија
Ostale studije u gradu Chicago
- Рак дојке59 студија
- Немалоклетни карцином плућа59 студија
- Рак (све врсте)51 студија
- Рак простате45 студија
- Рак плућа43 студија
- Метастатски карцином42 студија
- Гојазност40 студија
- Рак јајника36 студија
- Колоректални карцином32 студија
- Шлог31 студија
- Плоскоклеточни карцином главе и врата29 студија
- Гојазност29 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.